Irene Rivero‐Calle

4.4k total citations · 1 hit paper
87 papers, 1.4k citations indexed

About

Irene Rivero‐Calle is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Irene Rivero‐Calle has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Epidemiology, 27 papers in Infectious Diseases and 18 papers in Health. Recurrent topics in Irene Rivero‐Calle's work include Respiratory viral infections research (32 papers), Pneumonia and Respiratory Infections (30 papers) and Vaccine Coverage and Hesitancy (18 papers). Irene Rivero‐Calle is often cited by papers focused on Respiratory viral infections research (32 papers), Pneumonia and Respiratory Infections (30 papers) and Vaccine Coverage and Hesitancy (18 papers). Irene Rivero‐Calle collaborates with scholars based in Spain, United States and United Kingdom. Irene Rivero‐Calle's co-authors include Federico Martinón‐Torres, José Gómez Rial, Antonio Salas, Jacobo Pardo‐Seco, Carmen Rodríguez‐Tenreiro, Antonio José Justicia-Grande, Pablo Obando-Pacheco, Alberto Gómez‐Carballa, Miriam Cebey‐López and Asunción Mejías and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Irene Rivero‐Calle

79 papers receiving 1.4k citations

Hit Papers

Respiratory Syncytial Virus Seasonality: A Global Overview 2018 2026 2020 2023 2018 50 100 150 200 250

Peers

Irene Rivero‐Calle
Su Eun Park South Korea
Sharon Balter United States
Anna M. Bramley United States
Dat Tran Canada
Pietro G. Coen United Kingdom
Irene Rivero‐Calle
Citations per year, relative to Irene Rivero‐Calle Irene Rivero‐Calle (= 1×) peers George Zahariadis

Countries citing papers authored by Irene Rivero‐Calle

Since Specialization
Citations

This map shows the geographic impact of Irene Rivero‐Calle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Rivero‐Calle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Rivero‐Calle more than expected).

Fields of papers citing papers by Irene Rivero‐Calle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Rivero‐Calle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Rivero‐Calle. The network helps show where Irene Rivero‐Calle may publish in the future.

Co-authorship network of co-authors of Irene Rivero‐Calle

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Rivero‐Calle. A scholar is included among the top collaborators of Irene Rivero‐Calle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Rivero‐Calle. Irene Rivero‐Calle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García, Francisco José Álvarez, et al.. (2025). Calendario de vacunaciones e inmunizaciones de la Asociación Española de Pediatría: recomendaciones 2025. Anales de Pediatría. 102(1). 503713–503713. 2 indexed citations
2.
Moreno‐Galarraga, Laura, César García Vera, Irene Rivero‐Calle, et al.. (2025). Investigación pediátrica en España: desafíos y oportunidades. Anales de Pediatría. 103(1). 503854–503854.
3.
Mallah, Narmeen, Jacobo Pardo‐Seco, Irene Rivero‐Calle, et al.. (2024). COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population. Human Vaccines & Immunotherapeutics. 20(1). 2350817–2350817. 2 indexed citations
4.
Mallah, Narmeen, Jacobo Pardo‐Seco, Olaia Pérez‐Martínez, et al.. (2024). Short‐ and mid‐term morbidity and primary‐care burden due to infant respiratory syncytial virus infection: A Spanish 6‐year population‐based longitudinal study. Pediatric Allergy and Immunology. 35(5). e14131–e14131. 10 indexed citations
5.
García, Francisco José Álvarez, María José Cilleruelo Ortega, María Garcés‐Sánchez, et al.. (2023). Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations. SHILAP Revista de lepidopterología. 98(1). 58.e1–58.e10. 8 indexed citations
6.
Gómez‐Carballa, Alberto, María José Currás-Tuala, Sara Pischedda, et al.. (2023). Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia. Genes & Diseases. 11(3). 100981–100981. 1 indexed citations
7.
Mallah, Narmeen, Jacobo Pardo‐Seco, Susana Mirás‐Carballal, et al.. (2023). Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons. Archivos de Bronconeumología. 59(8). 531–533. 2 indexed citations
8.
Gómez‐Carballa, Alberto, Jacobo Pardo‐Seco, Sara Pischedda, et al.. (2022). Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics. Environmental Research. 215(Pt 2). 114288–114288. 9 indexed citations
9.
Pardo‐Seco, Jacobo, Narmeen Mallah, Carmen Durán‐Parrondo, et al.. (2022). Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain. International Journal of Environmental Research and Public Health. 19(7). 4039–4039. 6 indexed citations
10.
Mallah, Narmeen, Jacobo Pardo‐Seco, Carmen Durán‐Parrondo, et al.. (2022). Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain. Environmental Research. 215(Pt 2). 114252–114252. 16 indexed citations
12.
Pardo‐Seco, Jacobo, Nacho Aguiló, Ana Dacosta-Urbieta, et al.. (2021). BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies. EBioMedicine. 65. 103254–103254. 11 indexed citations
13.
Rivero‐Calle, Irene, et al.. (2020). Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Rial, José Gómez, Irene Rivero‐Calle, Antonio Salas, & Federico Martinón‐Torres. (2020). <p>Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy</p>. Infection and Drug Resistance. Volume 13. 2485–2493. 89 indexed citations
15.
Rivero‐Calle, Irene, José Gómez Rial, Louis Bont, et al.. (2020). TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human Vaccines & Immunotherapeutics. 17(3). 759–772. 1 indexed citations
16.
Gómez‐Carballa, Alberto, Miriam Cebey‐López, Jacobo Pardo‐Seco, et al.. (2019). A qPCR expression assay of IFI44L gene differentiates viral from bacterial infections in febrile children. Scientific Reports. 9(1). 11780–11780. 25 indexed citations
17.
Rivero‐Calle, Irene, Peter Francis Raguindin, José Gómez Rial, Carmen Rodríguez‐Tenreiro, & Federico Martinón‐Torres. (2019). <p>Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By <em>Neisseria meningitidis</em> Serogroup B</p>. Infection and Drug Resistance. Volume 12. 3169–3188. 27 indexed citations
18.
Rivero‐Calle, Irene, et al.. (2019). Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infants. Expert Opinion on Drug Safety. 18(4). 253–259. 6 indexed citations
19.
Rial, José Gómez, et al.. (2018). Rotavirus infection beyond the gut. Infection and Drug Resistance. Volume 12. 55–64. 33 indexed citations
20.
Rivero‐Calle, Irene, et al.. (2016). Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project). BMC Infectious Diseases. 16(1). 64–64. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026